BPC 157 has not been approved by FDA and should only be used in laboratory settings
Compounds like TB-500 (Thymosin Beta-4) are being studied for their effects on cell migration and anti-inflammatory properties, often in conjunction with BPC-157
What role does personalized medicine play in the IV glutathione treatment market?Personalized medicine enables healthcare providers to tailor glutathione infusion protocols based on individual health goals, lifestyle factors, and biomarker assessments
However, discontinuation rates are similar for both treatments (approximately 6%), suggesting that while CagriSema causes more frequent gastrointestinal symptoms, they are generally manageable
However, ongoing IV treatments can be costly and time-consuming, making them less practical for long-term use
Which dogs are most likely to benefit from antioxidant support